SciVision Biotech Inc. (TPE:1786)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
79.80
+0.60 (0.76%)
Jan 22, 2026, 1:35 PM CST
-34.05%
Market Cap5.72B
Revenue (ttm)890.43M
Net Income (ttm)164.72M
Shares Out72.19M
EPS (ttm)2.24
PE Ratio35.39
Forward PEn/a
Dividend3.25 (4.05%)
Ex-Dividend DateApr 25, 2025
Volume175,872
Average Volume334,785
Open79.70
Previous Close79.20
Day's Range78.80 - 79.90
52-Week Range71.50 - 129.50
Beta0.48
RSI56.18
Earnings DateMar 6, 2026

About SciVision Biotech

SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in international trade; wholesale of medical equipment and cosmetics; and provides management advisory services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan. [Read more]

Sector Healthcare
Founded 1990
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1786
Full Company Profile

Financial Performance

In 2024, SciVision Biotech's revenue was 883.31 million, an increase of 23.89% compared to the previous year's 712.99 million. Earnings were 242.25 million, an increase of 36.17%.

Financial Statements